Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair Noyce

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Movement Disorders : Official Journal of the Movement Disorder Society|December 23, 2023
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease TrialsCristina Gonzalez-Robles, Michèle Bartlett, Matthew Burnell, et al.
Movement Disorders Clinical Practice|November 19, 2024
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based StudyPhilipp Mahlknecht, Simon Leiter, Corinne Horlings, et al.
Journal of Parkinson'S Disease|August 7, 2023
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial InitiativeCristina Gonzalez-Robles, Rimona S Weil, Daniel van Wamelen, et al.
Neurobiology of Disease|November 5, 2023
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI studyMarco Toffoli, Harneek Chohan, Stephen Mullin, et al.
Journal of Neurology|July 10, 2025
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseasesAnnabelle Coleman, Alexiane Touzé, Mena Farag, et al.
The Lancet Regional Health. Europe|March 10, 2023
Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesGiovanni B Frisoni, Daniele Altomare, Federica Ribaldi, et al.
Nature Communications|December 5, 2022
Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effectsLynne Krohn, Karl Heilbron, Cornelis Blauwendraat, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Movement Disorders : Official Journal of the Movement Disorder Society|December 23, 2023
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease TrialsCristina Gonzalez-Robles, Michèle Bartlett, Matthew Burnell, et al.
Movement Disorders Clinical Practice|November 19, 2024
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population-based StudyPhilipp Mahlknecht, Simon Leiter, Corinne Horlings, et al.
Journal of Parkinson'S Disease|August 7, 2023
Outcome Measures for Disease-Modifying Trials in Parkinson's Disease: Consensus Paper by the EJS ACT-PD Multi-Arm Multi-Stage Trial InitiativeCristina Gonzalez-Robles, Rimona S Weil, Daniel van Wamelen, et al.
Neurobiology of Disease|November 5, 2023
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI studyMarco Toffoli, Harneek Chohan, Stephen Mullin, et al.
Journal of Neurology|July 10, 2025
Evaluating finger-prick blood collection for remote quantification of neurofilament light in neurological diseasesAnnabelle Coleman, Alexiane Touzé, Mena Farag, et al.
The Lancet Regional Health. Europe|March 10, 2023
Dementia prevention in memory clinics: recommendations from the European task force for brain health servicesGiovanni B Frisoni, Daniele Altomare, Federica Ribaldi, et al.
Nature Communications|December 5, 2022
Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effectsLynne Krohn, Karl Heilbron, Cornelis Blauwendraat, et al.
Pageof 3